The UK is witnessing a noticeable surge in interest surrounding entheogenic substances. Beyond the well-established use of psilocybin and LSD, researchers and enthusiasts are increasingly delving into less-charted areas, particularly this powerful hallucinogen and the relatively new cannabinoid, CBG. The evolving movement encompasses clinical tr… Read More